Review article · 2023

Evaluating physiochemical properties of FDA-approved orally administered drugs

Tanner C. Reese, Anvita Devineni, Tristan Smith, Ismail Lalami, Jung‐Mo Ahn, Ganesh V. Raj

Expert Opinion on Drug Discovery, 19(2), 225–238 · Published 3 November 2023 · DOI 10.1080/17460441.2023.2275617

View at the publisherCite this paper

In brief

“Evaluating physiochemical properties of FDA-approved orally administered drugs” is a 2023 review article by Tanner C. Reese and 5 co-authors, published in Expert Opinion on Drug Discovery. OpenAlex counts 21 citations as of 15 November 2026, which puts it in the top 5% of works published in 2023 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
21
Most cited in
2026 (12)
Field-weighted impact
0.34
References
156
Authors
6

Abstract

INTRODUCTION: Analyses of orally administered FDA-approved drugs from 1990 to 1993 enabled the identification of a set of physiochemical properties known as Lipinski's Rule of Five (Ro5). The original Ro5 and extended versions still remain the reference criteria for drug development programs. Since many bioactive compounds do not conform to the Ro5, we validated the… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Reese, T. C., Devineni, A., Smith, T., Lalami, I., Ahn, J., & Raj, G. V. (2023). Evaluating physiochemical properties of FDA-approved orally administered drugs. Expert Opinion on Drug Discovery, 19(2), 225–238. https://doi.org/10.1080/17460441.2023.2275617

MLA 9

Reese, Tanner C., et al. “Evaluating physiochemical properties of FDA-approved orally administered drugs.” Expert Opinion on Drug Discovery, vol. 19, no. 2, 2023, pp. 225–238. https://doi.org/10.1080/17460441.2023.2275617.

Chicago

Reese, Tanner C., Anvita Devineni, Tristan Smith, Ismail Lalami, Jung‐Mo Ahn, and Ganesh V. Raj. 2023. “Evaluating physiochemical properties of FDA-approved orally administered drugs.” Expert Opinion on Drug Discovery 19 (2): 225–238. https://doi.org/10.1080/17460441.2023.2275617.

Harvard

Reese, T. C. et al. (2023) ‘Evaluating physiochemical properties of FDA-approved orally administered drugs’, Expert Opinion on Drug Discovery, 19(2), pp. 225–238. doi:10.1080/17460441.2023.2275617.

IEEE

T. C. Reese, A. Devineni, T. Smith, I. Lalami, J. Ahn, and G. V. Raj, “Evaluating physiochemical properties of FDA-approved orally administered drugs,” Expert Opinion on Drug Discovery, vol. 19, no. 2, pp. 225–238, 2023, doi: 10.1080/17460441.2023.2275617.

BibTeX

@article{reese2023evaluating,
  title     = {{Evaluating physiochemical properties of FDA-approved orally administered drugs}},
  author    = {Reese, Tanner C. and Devineni, Anvita and Smith, Tristan and Lalami, Ismail and Ahn, Jung‐Mo and Raj, Ganesh V.},
  journal   = {Expert Opinion on Drug Discovery},
  year      = {2023},
  volume    = {19},
  number    = {2},
  pages     = {225--238},
  doi       = {10.1080/17460441.2023.2275617},
  url       = {https://doi.org/10.1080/17460441.2023.2275617}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202433
202566
20261212

Its field-weighted citation impact is 0.34: it has been cited 0.34 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods

  • Lipinski's rule of five
  • physicochemical properties
  • oral bioavailability
  • drug-likeness
  • drug development
  • chemical diversity

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Reese, T. C., Devineni, A., Smith, T., Lalami, I., Ahn, J., & Raj, G. V. (2023). Evaluating physiochemical properties of FDA-approved orally administered drugs. Expert Opinion on Drug Discovery, 19(2), 225–238. https://doi.org/10.1080/17460441.2023.2275617

How many times has this paper been cited?

21 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Tanner C. Reese, Anvita Devineni, Tristan Smith, Ismail Lalami, Jung‐Mo Ahn, Ganesh V. Raj.

What is the DOI of this paper?

10.1080/17460441.2023.2275617. The permanent link is https://doi.org/10.1080/17460441.2023.2275617.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.